Company page

Apex Biotechnology Corp.

Apex Biotechnology Corp. is a public company listed on the Taiwan stock market under the ticker 1733. The company has a market capitalization of approximately NT$92.39 million. Apex Biotechnology focuses on the development and manufacturing of innovative medical products and solutions.

profile1733:TWSEAI content: aiUpdated June 24, 2026/company/apex-biotechnology-corp/c-nh2uzkut
Apex Biotechnology Corp. logo
Ticker
1733:TWSE
Asset type
Stock
Market cap
$92.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
TWSE
Currency
TWD